E7 11-19 placement and orientation dictate CD8 + T cell response in structurally defined spherical nucleic acid vaccines
Science Advances · 13.02.2026 · 12 (7)
DOI: 10.1126/sciadv.aec3876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 13.02.2026. Verfasst von Jeongmin Hwang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Northwestern University, Evanston, IL 60208, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Papillomavirus E7 Proteins, Vaccines, DNA, Cancer Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Science Foundation, National Institutes of Health.
Abstract (Originalsprache)
To develop effective nanostructured immunotherapeutics, identifying structural parameters that maximize immune response is essential. Spherical nucleic acids (SNAs) provide a modular platform for coordinated antigen-adjuvant delivery, where subtle structural differences can markedly influence potency. Herein, three SNAs were designed with HLA-A2–restricted HPV16 E7 11-19 peptide and CpG adjuvant, nearly identical in composition but differing in antigen presentation. All enhanced dendritic cell activation and CD8 + T cell cytotoxicity in primary human cells compared to peptide-CpG admixture; however, one variant, N-HSNA, elicited the strongest response, inducing ~8-fold higher interferon-γ secretion and ~2.5-fold greater cytotoxicity. In tumor-bearing AAD mice, N-HSNA reduced tumor burden by ~3.5-fold, prolonged survival, and expanded CD8 + T cells. Transcriptomic profiling revealed up-regulation of activation genes and suppression of exhaustion markers. In patient-derived HPV + head and neck cancer spheroids, N-HSNA enhanced cytotoxicity ~2.5-fold, establishing antigen placement and orientation as key parameters for translational cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.
- International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208, USA.
- Interdisciplinary Biological Sciences Graduate Program, Northwestern University, Evanston, IL 60208, USA.
- Department of Medicine, Hematology/Oncology Division, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
- Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208, USA.
ORCID-Profile: Jeongmin Hwang, Tonatiuh A Ocampo, Vinzenz Mayer, Janice Kang, Krishna S Paranandi, Young Jun Kim, Zhenyu Han, John P Cavaliere, Sergej Kudruk, Jochen H Lorch, Chad A Mirkin
Förderung
- NCI NIH HHS
- National Science Foundation
- National Institutes of Health
- National Cancer Institute
- Lefkofsky Family Foundation
- International Institute for Nanotechnology, Northwestern University
- Robert H. Lurie Cancer Center’s Translation Bridge Training Program
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Zitieren
APA
Hwang, J., Ocampo, T. A., Mayer, V., Kang, J., Paranandi, K. S., Kim, Y. J., Han, Z., Cavaliere, J. P., Kudruk, S., Lorch, J. H., & Mirkin, C. A. (2026). E7 11-19 placement and orientation dictate CD8 + T cell response in structurally defined spherical nucleic acid vaccines. Science Advances, 12(7). https://doi.org/10.1126/sciadv.aec3876
Vancouver
Hwang J, Ocampo TA, Mayer V, Kang J, Paranandi KS, Kim YJ, et al. E7 11-19 placement and orientation dictate CD8 + T cell response in structurally defined spherical nucleic acid vaccines. Science Advances. 2026;12(7). doi:10.1126/sciadv.aec3876
BibTeX
@article{Hwang2026,
author = {Hwang, Jeongmin and Ocampo, Tonatiuh A and Mayer, Vinzenz and Kang, Janice and Paranandi, Krishna S and Kim, Young Jun and Han, Zhenyu and Cavaliere, John P and Kudruk, Sergej and Lorch, Jochen H and Mirkin, Chad A},
title = {E7 11-19 placement and orientation dictate CD8 + T cell response in structurally defined spherical nucleic acid vaccines},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {7},
doi = {10.1126/sciadv.aec3876}
}
EUVIMED